Home›People›David Llewellyn
David Llewellyn

David Llewellyn

President and Chief Executive Officer, director at Trailhead Biosystems.

ExecutiveDirector
Updated Nov 9, 2026·Latest SEC filing Jul 30, 2026·Suggest an edit

About David Llewellyn

David Llewellyn is a president and chief executive officer, director at Trailhead Biosystems.

Experience

This experience comes from David Llewellyn's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Llewellyn in the role, so the role may have started earlier or lasted longer.

Trailhead Biosystems Inc. Current
President and CEO (2025 – Present)
Director
2025 – Present · Beachwood, OH
Human cell products for drug discovery and cell therapy research.
STEMCELL Technologies
Chief Strategy Officer (CSO)
2006 – 2025
AQUINOX PHARMACEUTICALS INC
Director, Business Operations
2007 – 2010
MethylGene Inc.
Senior Research Scientist
2001 – 2004

Key Colleagues at Startups

The people David Llewellyn works with at each company, as listed on that company's latest Form D.

Trailhead Biosystems Inc. · Form D/A, Jul 30, 2026
HH
Wolfgang Hofmann
Wolfgang Hofmann
Board Member, Trailhead Biosystems
Craig Nemiroff
Craig Nemiroff
Managing Director, MAK Capital
Joshua Snow
Joshua Snow
Chief Commercial Officer
Jan Jensen
Jan Jensen
Board Member, Trailhead Biosystems
Divya Trivedi
Divya Trivedi
Chief Operating Officer
Michael Kaufman
Michael Kaufman
Chief Executive Officer, MAK Capital and director

Sources

  1. SECTrailhead Biosystems Inc. Form D/A, filed Jul 30, 2026